Compare Cassava Sciences Inc (FLNA) vs Huntington Ingalls Industries Inc (HII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Huntington Ingalls Industries Inc — how do they compare? Cassava Sciences Inc trades at $1.1 (market cap $53.14M), while Huntington Ingalls Industries Inc trades at $271.56 (market cap $10.95B). The key difference: Huntington Ingalls Industries Inc is far larger — about 206.1× Cassava Sciences Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.99% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | HII | |
|---|---|---|
Market Cap | $53.14M | $10.95B |
Sector | Health | Technology |
52-Week High | $4.64 | $453.73 |
52-Week Low | $1.09 | $252.93 |
Enterprise Value | -$33.43M | $13.66B |
Dividend Yield | — | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HII trades at $272.26, down 2.76% on the day, with a bearish technical signal despite strong fundamentals. The company maintains consistent profitability with a 4.71% net margin and has beaten earnings estimates for three consecutive quarters. Recent developments include shipbuilding milestones and new defense contracts, supporting revenue growth projections to $12.8B in 2026.
The stock presents a compelling value opportunity with a P/E of 18.05 and P/S of 0.85, trading at a discount to analyst consensus target of $354.50. However, near-term technical weakness and defense sector volatility pose risks. Wall Street sentiment is mixed with 44% buy ratings, suggesting cautious optimism for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →
